Given it is approved in Australia and it is actually working in real life on humans, management are confident. I believe this is just a rubber stamp to comply with FDA processes. Why the market reacts to the announcement in this poor way is puzzling me. Any other bio would see a jump in the sp 10%, 20% and even 50%. Is it manipulation? By whom? Management are doing great job in advancing the product which is what they should be their main focus. However, the recent capital raise at $0.37 should have been done at a premium (not a discount) to SP. Even if it is at a small premium especially they didn't need the cach.
I am confident that one day, the sp will rise to reflect the true value of this great company.
Given it is approved in Australia and it is actually working in...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.015(3.85%) |
Mkt cap ! $78.49M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.5¢ | $54.65K | 144.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 44995 | 2 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
37.5¢ |
Change
-0.015 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.0¢ | 37.5¢ | 37000 | ||
| Last updated 15.09pm 07/05/2024 ? | |||||
| OCC (ASX) Chart |